ストックスクリーナーアプリを入手
36.48
0.16%
0.07
前日終値:
$36.41
開ける：
$37
24時間の取引高:
396.27K
Relative Volume:
0.14
時価総額：
$5.79B
収益：
$264.79M
当期純損益:
$-14.36M
株価収益率:
-331.64
EPS:
-0.11
ネットキャッシュフロー:
$-28.11M
1週間 パフォーマンス:
+3.78%
1か月 パフォーマンス:
-16.05%
6か月 パフォーマンス:
+7.64%
1年 パフォーマンス:
+124.98%
1日の値動き範囲:
$36.17
$37.10
1週間の範囲:
$34.32
$37.10
52週間の値動き範囲:
$15.16
$46.48
Tg Therapeutics Inc Stock (TGTX) Company Profile
名前
Tg Therapeutics Inc
セクター
電話
(212) 554-4484
住所
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
TGTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
36.47 | 5.59B | 264.79M | -14.36M | -28.11M | -0.11 |
|
ONC
Beone Medicines Ltd Adr
|
260.02 | 26.01B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
448.83 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.365 | 40.54M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
85.97 | 6.29B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
495.01 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-29 | 開始されました | TD Cowen | Buy |
| 2023-08-02 | アップグレード | Goldman | Sell → Neutral |
| 2023-06-26 | 再開されました | Jefferies | Buy |
| 2022-05-20 | 開始されました | BofA Securities | Underperform |
| 2022-02-23 | 繰り返されました | B. Riley Securities | Buy |
| 2021-11-15 | ダウングレード | Goldman | Neutral → Sell |
| 2021-04-20 | 開始されました | Goldman | Neutral |
| 2021-04-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-01 | 開始されました | JP Morgan | Overweight |
| 2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-05 | 開始されました | Evercore ISI | Outperform |
| 2020-01-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-27 | 再開されました | B. Riley FBR | Buy |
| 2019-02-06 | 再開されました | Jefferies | Buy |
| 2018-09-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 繰り返されました | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 再開されました | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 再開されました | H.C. Wainwright | Buy |
| 2017-04-25 | 開始されました | Jefferies | Buy |
| 2017-03-06 | 繰り返されました | FBR & Co. | Outperform |
| 2016-10-06 | 再開されました | Brean Capital | Buy |
| 2016-05-27 | 開始されました | SunTrust | Buy |
| 2015-12-01 | 開始されました | FBR Capital | Outperform |
| 2015-09-09 | 開始されました | Raymond James | Strong Buy |
| 2015-08-12 | 再開されました | H.C. Wainwright | Buy |
| 2015-06-19 | 繰り返されました | Brean Capital | Buy |
| 2014-12-11 | 繰り返されました | ROTH Capital | Buy |
| 2014-12-10 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Tg Therapeutics Inc (TGTX) 最新ニュース
TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference - The Manila Times
TG Therapeutics CEO Fireside Chat: Key Updates Expected at Major Healthcare Conference - Stock Titan
TG Therapeutics Announces Data Presentations for BRIUMVI in Mult - GuruFocus
TG Therapeutics shares MS drug trial updates By Investing.com - Investing.com India
TG Therapeutics shares MS drug trial updates - Investing.com
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting | TGTX Stock News - GuruFocus
TG Therapeutics Announces Data Presentations for BRIUMVI in - GlobeNewswire
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - Yahoo Finance
TG Therapeutics: Estimates Could Soon Be Raised Again (NASDAQ:TGTX) - Seeking Alpha
Man Group plc Purchases Shares of 9,589 TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting | TGTX Stock News - GuruFocus
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - The Manila Times
TG Therapeutics Announces Schedule of Data Presentations - GlobeNewswire
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at ... - Eagle-Tribune
How To Trade (TGTX) - news.stocktradersdaily.com
Exploring 3 High Growth Tech Stocks In The US Market - Yahoo Finance
TG Therapeutics' (NASDAQ:TGTX) Weak Earnings May Only Reveal A Part Of The Whole Picture - simplywall.st
Investor Calendar Invites You to the TG Therapeutics, Inc. Third Quarter 2016 Earnings Conference Call and Webcast Live on Monday, November 7, 2016 - ACCESS Newswire
(TGTX) Long Term Investment Analysis - news.stocktradersdaily.com
TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook - MSN
Decoding TG Therapeutics Inc (TGTX): A Strategic SWOT Insight - GuruFocus
TG Therapeutics, Inc. (TGTX): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey
10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey
TG Therapeutics raises 2025 guidance to $560M, driven by BRIUMVI adoption - MSN
TG Therapeutics stock sinks on profit miss - MSN
TG Therapeutics Q1 2025 Earnings Call Transcript - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2025 Earnings Call Transcript - Insider Monkey
TG Therapeutics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Str - GuruFocus
Jefferies maintains Buy on TGTX stock with $46 target By Investing.com - Investing.com Nigeria
TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Strong BRIUMVI Sales and Increased ... - Yahoo Finance
TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Strong BRIUMVI Sales and Increased ... By GuruFocus - Investing.com Canada
TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook By Stocktwits - Investing.com India
TG Therapeutics: Q1 Earnings Snapshot - MySA
TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show - Benzinga
Why TG Therapeutics Stock Was Tumbling Today - AOL.com
TGTX Stock Dips Despite Surging Revenue and Profitability - GuruFocus
Jefferies maintains Buy on TGTX stock with $46 target - Investing.com
TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges (TGTX) - Seeking Alpha
TG Therapeutics (TGTX) Stock Falls After Earnings Miss Despite Raised Guidance - GuruFocus
TG Therapeutics stock sinks on profit miss (TGTX:NASDAQ) - Seeking Alpha
Strong Q1 Performance for TG Therapeutics (TGTX) with BRIUMVI Growth - GuruFocus
Earnings call transcript: TG Therapeutics misses Q1 2025 EPS forecast, shares dip - Investing.com
TG Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
TG Therapeutics Stock Tumbles After Q1 Earnings Fall Short Of Wall Street Estimates: But Retail’s Optimistic - MSN
TG Therapeutics (TGTX) Lags Q1 Earnings Estimates - Yahoo Finance
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance - GlobeNewswire
TG Therapeutics (TGTX) Misses Q1 EPS Estimates, Raises 2025 Reve - GuruFocus
TG Therapeutics Inc (TGTX) Reports Q1 2025 Revenue of $119.7 Million, Surpassing Estimates - GuruFocus
TG Therapeutics' Q1 Swings to Net Income, Revenue Rises; Full-Year 2025 BRIUMVI Revenue Guidance Updated - marketscreener.com
Tg Therapeutics Inc (TGTX) 財務データ
収益
当期純利益
現金流量
EPS
Tg Therapeutics Inc (TGTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Power Sean A | CFO |
Jan 06 '25 |
Sale |
28.53 |
10,021 |
285,939 |
660,611 |
0.87%
0.19%
大文字化:
|
ボリューム (24 時間):